Investing
The round brings the company's total raise to $93 million.
The company will use the funds to speed up its growth.
The California-based company will use the funds to acquire regulatory clearance for its miLens offering.
The company will develop experiences that train individuals in the biopharmaceutical and life sciences sectors.
Initially filed in 2022, the complaint alleged the company's representatives misled investors following its $18.5 billion acquisition of Livongo.
Lynne Chou O'Keefe, founder and managing partner of Define Ventures, tells MobiHealthNews what characteristics of a company are essential to garner investment.
The hybrid platform offers Medicare Advantage recipients behavioral health services. It will use the funds to grow its partnerships with insurance providers.
The funding comes three months after the company announced it added AI-enabled imaging features and new indications expanding xvision's use to the whole spine.
Early-stage venture fund AlleyCorp led the round.
The company also added two new members to its board of directors and a new senior vice president for Medicare Advantage.